1032824-91-1

Basic information

• Product Name: 4-(hydroxyMethyl)piperidine-1-carbonitrile
• Synonyms: 4-(hydroxyMethyl)piperidine-1-carbonitrile;4-(Hydroxymethyl)Piperidine-1-Carbonitrile(WX640239)
• CAS NO: 1032824-91-1
• Molecular Formula: C₇H₁₂N₂O
• Molecular Weight: 140.18298
• EINECS: -0
• Mol File: 1032824-91-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(hydroxyMethyl)piperidine-1-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(hydroxyMethyl)piperidine-1-carbonitrile(1032824-91-1)
• EPA Substance Registry System: 4-(hydroxyMethyl)piperidine-1-carbonitrile(1032824-91-1)

Safety Data

• Hazardous Substances Data: 1032824-91-1(Hazardous Substances Data)

Usage

General Description

4-(Hydroxymethyl)Piperidine-1-Carbonitrile is a chemical compound with the molecular formula C7H11N2O. It is a piperidine derivative with a hydroxymethyl group and a carbonitrile functional group. 4-(Hydroxymethyl)Piperidine-1-Carbonitrile has potential applications in the pharmaceutical industry, particularly in the development of new drugs and medications. It may be used as an intermediate in the synthesis of various organic compounds and pharmaceutical ingredients. Its unique chemical structure makes it a versatile building block for the creation of new drugs and may have potential therapeutic properties. However, further research and testing are required to fully understand its potential applications and properties.

Upstream product

• 6457-49-4 4-piperidinemethanol 
• 172876-96-9 3-oxo-1λ³-benzo[d][1,2]iodaoxole-1(3H)-carbonitrile 
• 557-21-1 zinc(II) cyanide 
• 123855-51-6 tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate 
• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 
• 90748-01-9 4-piperidinemethanol hydrochloride 
• 506-68-3 bromocyane 
• 498-94-2 isonipecotic acid 

Downstream Products

• 1351345-55-5 [(3R,4S)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]-4-methylpyrimidin-2-yl}-4-(2,4,5-trifluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester 
• 1351338-59-4 (3R,4S)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]-4-methylpyrimidin-2-yl}-4-(2,4,5-trifluorophenyl)pyrrolidin-3-ylamine p-toluenesulfonate 
• 1351345-54-4 ((3R,4S)-4-(2,5-difluorophenyl)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]-4-methylpyrimidin-2-yl}pyrrolidin-3-yl)carbamic acid tert-butyl ester 
• 1351338-57-2 (3R,4S)-4-(2,5-difluorophenyl)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]-4-methylpyrimidin-2-yl}pyrrolidin-3-ylamine p-toluenesulfonate 
• 1351345-53-3 ((3R,4S)-4-(4-chloro-2-fluorophenyl)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]pyrimidin-2-yl}pyrrolidin-3-yl)carbamic acid tert-butyl ester 
• 1351338-52-7 ((3R,4S)-4-(4-chloro-2-fluorophenyl)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]pyrimidin-2-yl}pyrrolidin-3-yl)amine 
• 1351345-52-2 [(3R,4S)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]pyrimidin-2-yl}-4-(2,4,5-trifluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester 
• 1351338-51-6 (3R,4S)-1-{5-[l-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]pyrimidin-2-yl}-4-(2,4,5-trifluorophenyl)pyrrolidin-3-ylamine 
• 1351345-51-1 ((3R,4S)-4-(2,4-difluorophenyl)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]pyrimidin-2-yl}pyrrolidin-3-yl)carbamic acid tert-butyl ester 
• 1351345-80-6 C₃₁H₄₀F₂N₆O₄ 
• 1351343-45-7 ((3R,4S)-4-(2,5-difluoro-phenyl)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]-4-methoxy-pyrimidin-2-yl}pyrrolidin-3-yl)carbamic acid tert-butyl ester 
• 1351342-38-5 [(3R,4S)-1-{5-[1-(3-ethyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethoxy]pyrimidin-2-yl}-4-(2,4,5-trifluorophenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester 
• 1351341-81-5 [(3R,4S)-4-(2,5-difluorophenyl)-1-(5-{[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-4-ylmethyl]amino}pyrimidin-2-yl)pyrrolidin-3-yl]carbamic acid tert-butyl ester 
• 1032825-19-6 (1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulfonate 

Relevant articles and documents

N-Cyanation of Primary and Secondary Amines with Cyanobenzio-doxolone (CBX) Reagent

An efficient electrophilic N-cyanation of amines with a stable and less-toxic cyanobenziodoxole reagent towards the synthesis of cyanamides is disclosed. This synthetically practicable strategy allows the construction of a wide variety of cyanamides under very mild and simple conditions with a broad functional group compatibility, and showcases a huge potential in late-stage modification of complex molecules.

NOVEL COMPOUNDS AS GPR119 AGONISTS

The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.

BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS

The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.